tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Dyskinesia, Drug-Induced D004409 15 associated lipids
Dysgammaglobulinemia D004406 3 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Down Syndrome D004314 18 associated lipids
Digestive System Diseases D004066 3 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dermatomyositis D003882 2 associated lipids
Dermatomycoses D003881 17 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis D003872 30 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Dehydration D003681 11 associated lipids
Deglutition Disorders D003680 2 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Cystitis D003556 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cutis Laxa D003483 1 associated lipids
Cryptococcosis D003453 3 associated lipids
Crohn Disease D003424 12 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Cough D003371 19 associated lipids
Corneal Diseases D003316 13 associated lipids
Connective Tissue Diseases D003240 2 associated lipids
Confusion D003221 4 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Collagen Diseases D003095 2 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colitis D003092 69 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Cicatrix D002921 9 associated lipids
Chronic Disease D002908 7 associated lipids
Hemophilia B D002836 3 associated lipids
Choline Deficiency D002796 16 associated lipids
Cholestasis D002779 23 associated lipids
Cholelithiasis D002769 16 associated lipids
Cheilitis D002613 2 associated lipids
Uterine Cervical Dysplasia D002578 2 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Brain Ischemia D002545 89 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cataract D002386 34 associated lipids
Catalepsy D002375 30 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Burns D002056 34 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchiolitis D001988 6 associated lipids
Brain Edema D001929 20 associated lipids
Brain Diseases D001927 27 associated lipids
Bradycardia D001919 13 associated lipids
Bone Diseases D001847 4 associated lipids
Body Weight D001835 333 associated lipids
Blindness D001766 6 associated lipids
Blepharitis D001762 4 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Biliary Fistula D001658 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Balanitis D001446 4 associated lipids
Bacterial Infections D001424 21 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Ataxia D001259 20 associated lipids
Ascites D001201 25 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arm Injuries D001134 1 associated lipids
Apraxias D001072 1 associated lipids
Anus Diseases D001004 3 associated lipids
Angioedema D000799 6 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Aneurysm, Dissecting D000784 2 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Anemia, Refractory D000753 3 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Bunnapradist S et al. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups. 2016 Transpl. Int. pmid:26953629
Velasco-Guardado A et al. Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD. 2016 Bone Marrow Transplant. pmid:26950379
Mehta RS et al. Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation. 2016 Br. J. Haematol. pmid:26947769
Kloster-Jensen K et al. Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids. 2016 J Diabetes Res pmid:26885529
Rotenstein L et al. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. 2016 Bone Marrow Transplant. pmid:27272445
Raschzok N et al. The impact of directly acting antivirals on the enzymatic liver function of liver transplant recipients with recurrent hepatitis C. 2016 Transpl Infect Dis pmid:27632190
Shen X et al. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. 2016 Sci Rep pmid:27580845
Nakamura H et al. Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases. 2016 Mod Rheumatol pmid:25036233
Khan S et al. Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. 2016 Eur J Pharm Biopharm pmid:27793753
Thölking G et al. Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation. 2016 Sci Rep pmid:27573493
Andrews LM et al. Consideration of the ethnic prevalence of genotypes in the clinical use of tacrolimus. 2016 Pharmacogenomics pmid:27790923
Tang J et al. Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. 2016 Transplant. Proc. pmid:27788813
Högerle BA et al. Challenging immunosuppression treatment in lung transplant recipients with kidney failure. 2016 Transpl. Immunol. pmid:26892232
Kolb M et al. Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation. 2016 Biol. Blood Marrow Transplant. pmid:26880117
Kimura H et al. Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan. 2016 Surg. Today pmid:26467558
Törlén J et al. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. 2016 Haematologica pmid:27662016
Žilinská Z et al. Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. 2016 Transplant. Proc. pmid:27788794
Gaballa S et al. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. 2016 Cancer pmid:27404668
Chang KT et al. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. 2016 J Microbiol Immunol Infect pmid:25315214
Brooks E et al. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet? 2016 Clin Pharmacokinet pmid:27138787
Rebora A Tacrolimus and oral lichen planus. Possible absorption after mucosal application? 2016 J Eur Acad Dermatol Venereol pmid:26372839
Ohe M et al. A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. 2016 Kaohsiung J. Med. Sci. pmid:27638410
Jin H et al. Clinical study of double dose of valsartan combined with tacrolimus in treatment of diabetic nephropathy. 2016 Eur Rev Med Pharmacol Sci pmid:26813471
Wang N et al. Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer. 2016 ACS Appl Mater Interfaces pmid:26809267
Pirojsakul K et al. Management of sensitized pediatric patients prior to renal transplantation. 2016 Pediatr. Nephrol. pmid:26801944
Guo YW et al. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients. 2016 World J. Gastroenterol. pmid:27350740
Sawada T et al. Experimental Studies on Protective Effects of FK506 Against Hepatic Ischemia-Reperfusion Injury. 2016 J. Med. Invest. pmid:27644569
Gabriel D et al. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. 2016 J Control Release pmid:27639683
Chen CA et al. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature. 2016 J Microbiol Immunol Infect pmid:26748735
Yoshida T et al. Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production. 2016 Eur J Pharm Biopharm pmid:26748381
Muñoz Gómez MM et al. [Tacrolimus-induced gynecomastia in a patient with polymyositis]. 2016 Med Clin (Barc) pmid:26678165
Ferjani H et al. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats. 2016 J. Physiol. Biochem. pmid:26746208
Vasu S et al. Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. 2016 Biol. Blood Marrow Transplant. pmid:26743340
Yoo EC et al. Developmental changes of MPA exposure in children. 2016 Pediatr. Nephrol. pmid:26743220
Yingfang F et al. Pimecrolimus micelle exhibits excellent therapeutic effect for Keratoconjunctivitis Sicca. 2016 Colloids Surf B Biointerfaces pmid:26731192
Pouché L et al. A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation. 2016 Pharmacogenomics pmid:26894651
Radziejewski K and Balicki I Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca. 2016 Acta Vet. Hung. pmid:27653428
Sommerer C et al. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. 2016 Trials pmid:26888217
Choi WJ et al. Oral administration of Lactococcus chungangensis inhibits 2,4-dinitrochlorobenzene-induced atopic-like dermatitis in NC/Nga mice. 2016 J. Dairy Sci. pmid:27289147
Rahnama-Moghadam S et al. Vesicular eruption in a 2-year-old boy. 2016 J Fam Pract pmid:27565104
Haasova M et al. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. 2016 Health Technol Assess pmid:27557331
Bapur Erduran F and Adışen E Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo. 2016 Photodermatol Photoimmunol Photomed pmid:27552312
Badr R et al. Assessment of global ischemic/reperfusion and Tacrolimus administration on CA1 region of hippocampus: gene expression profiles of BAX and BCL2 genes. 2016 Bratisl Lek Listy pmid:27546370
Tsuji T et al. Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. 2016 Allergol Int pmid:26666476
Speckmann T et al. Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells. 2016 J. Biol. Chem. pmid:26663079
Fang YP et al. What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. 2016 Int J Pharm pmid:26657274
Thao le Q et al. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. 2016 Int J Pharm pmid:26657273
Ishiwata Y et al. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study. 2016 Ther Drug Monit pmid:27559841
Lee C et al. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. 2016 Biomed. Pharmacother. pmid:26898446
Bargnoux AS et al. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method. 2016 Ther Drug Monit pmid:27494947
Arai K et al. A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation. 2016 Kobe J Med Sci pmid:27492209
Ren H et al. Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane. 2016 Am. J. Physiol. Renal Physiol. pmid:27488997
Albeiroti S et al. Evaluation of 2 Batched Pretreatment Systems for the Measurement of Whole Blood Tacrolimus on the ARCHITECT Immunoassay Analyzer. 2016 Lab Med pmid:27474776
Yu H et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study. 2016 BMC Nephrol pmid:27473469
Woolner K and Sauder M Periorbital erythema following alcohol ingestion during treatment with topical tacrolimus. 2016 CMAJ pmid:26598374
Park JS et al. A rapid and sensitive method to determine tacrolimus in rat whole blood using liquid-liquid extraction with mild temperature ultrasonication and LC-MS/MS. 2016 Arch. Pharm. Res. pmid:26589688
Filler G et al. Minimum mycophenolic acid levels are associated with donor-specific antibody formation. 2016 Pediatr Transplant pmid:26589470
Dabrowska-Zamojcin E et al. CCL2 gene polymorphism is associated with post-transplant diabetes mellitus. 2016 Int. Immunopharmacol. pmid:26802601
Yoshida S et al. Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. 2016 J. Med. Invest. pmid:27644556
Ashizuka S et al. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series. 2016 Dig. Dis. Sci. pmid:26470867
Kimsa M et al. Transforming growth factor β-related genes in human retinal pigment epithelial cells after tacrolimus treatment. 2016 Pharmacol Rep pmid:27372923
García-Delgado R et al. Systemic Absorption of Topical Tacrolimus in Metastatic Crohn Disease With Skin Ulcers. 2016 Actas Dermosifiliogr pmid:27372545
Gray JM and Ameduri RK Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient. 2016 Pediatr Transplant pmid:27371345
Tanriover B et al. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. 2016 Clin J Am Soc Nephrol pmid:27364616
Ordóñez-Robles M et al. Target genes of the Streptomyces tsukubaensis FkbN regulator include most of the tacrolimus biosynthesis genes, a phosphopantetheinyl transferase and other PKS genes. 2016 Appl. Microbiol. Biotechnol. pmid:27357227
Handisurya A et al. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. 2016 PLoS ONE pmid:26735686
Watanabe R et al. Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis. 2016 Mod Rheumatol pmid:25698368
Vignali D et al. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. 2016 Transplantation pmid:27306531
Tsuji H et al. Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. 2016 Intern. Med. pmid:27301503
Pizzo HP et al. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. 2016 Pediatr. Nephrol. pmid:27286686
Youssef M et al. Asymptomatic papulonodular lesions in zosteriform distribution in an immunocompromised patient. 2016 Int. J. Dermatol. pmid:26463835
Ferjani H et al. The evaluate and compare the effects of the Tacrolimus and Sirolimus on the intestinal system using an intestinal cell culture model. 2016 Toxicol. Mech. Methods pmid:26460985
Yamashita T et al. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. 2016 Cancer Chemother. Pharmacol. pmid:27217047
Tremblay S et al. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes. 2016 Prog Transplant pmid:27207408
Sharma A et al. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants. 2016 Prog Transplant pmid:27207404
Menninga NJ et al. Restless Legs Syndrome Following Lung Transplantation: Prevalence and Relationship With Tacrolimus Exposure. 2016 Prog Transplant pmid:27207403
Nankivell BJ et al. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. 2016 Transplantation pmid:27306529
Jebabli N et al. Consequences of erroneous phone transmission of tacrolimus blood concentration: A case report. 2016 Therapie pmid:27203160
Sasaki T et al. Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients. 2016 Clin. Rheumatol. pmid:25644583
Reeves TM et al. Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury. 2016 Exp. Neurol. pmid:27302680
O'Regan JA et al. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. 2016 J. Nephrol. pmid:26374111
Pirmez R et al. Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. 2016 Australas. J. Dermatol. pmid:27124649
Matsukawa T et al. Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD. 2016 Int. J. Hematol. pmid:27119977
Alvarez-Elías AC et al. CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. 2016 Transplant. Proc. pmid:27110018
Reiner J et al. After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. 2016 Transplant. Proc. pmid:27109987
Peng L et al. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy. 2016 J. Formos. Med. Assoc. pmid:26315481
Ruangkanchanasetr P et al. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients. 2016 Ann. Transplant. pmid:27980321
Castagna L et al. Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide. 2016 Bone Marrow Transplant. pmid:26595078
Cai SC et al. Topical calcineurin inhibitors in eczema and cancer association: A cohort study. 2016 J Dermatolog Treat pmid:27049893
Aldoss I et al. Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. 2016 Biol. Blood Marrow Transplant. pmid:27044907
Yamamoto T et al. Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. 2016 Aliment. Pharmacol. Ther. pmid:27040167
Taylor KM and Sparrow MP Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. 2016 Aliment. Pharmacol. Ther. pmid:27040166
Imamura CK et al. Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole. 2016 J Clin Pharmacol pmid:26239045
Lonowski S et al. Vitiligo: a potential autoimmune sequela of DRESS syndrome. 2016 Br. J. Dermatol. pmid:27038429
Wang Y et al. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method. 2016 Int J Pharm pmid:27034003
Jimbo H et al. Telangiectatic lichen sclerosus on the cheek successfully treated with topical tacrolimus. 2016 Eur J Dermatol pmid:27033557
Albano L et al. Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney Transplantation. 2016 Ann. Transplant. pmid:27122116
García-Bello JA et al. Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. 2016 Transplant. Proc. pmid:27110020
Gu C et al. Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model. 2016 Plast. Reconstr. Surg. pmid:27879593
Carrillo-Ibarra S et al. The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus. 2016 Oxid Med Cell Longev pmid:27872679